en

PRODUCT DETAIL

Armisarte 25 mg/ml infúzny koncentrát

Code 8206B
MA number EU/1/15/1063/002
Product Form: con inf 1x20 ml/500 mg (liek.inj.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
MAH, country: Actavis Group PTC ehf., Iceland
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01B ANTIMETABOLITES
L01BA Folic acid analogues
L01BA04 Pemetrexed
Shelf life: 18
Container: glass vial
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(3) hybrid application
MA issued: 18.01.2016
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 08.09.2020
eu-flag.png sk-flag.png